ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 223 filers reported holding ZAI LAB LTD in Q3 2021. The put-call ratio across all filers is 1.79 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $250 | -29.0% | 10,300 | -18.9% | 0.00% | -100.0% |
Q2 2023 | $352 | -71.2% | 12,700 | -65.5% | 0.00% | -50.0% |
Q1 2023 | $1,224 | -64.0% | 36,800 | -66.8% | 0.00% | -60.0% |
Q4 2022 | $3,398 | -99.7% | 110,700 | +285.7% | 0.01% | +400.0% |
Q3 2022 | $982,000 | -77.2% | 28,700 | -76.9% | 0.00% | -80.0% |
Q2 2022 | $4,304,000 | -80.2% | 124,114 | -64.0% | 0.01% | -81.5% |
Q4 2021 | $21,696,000 | -19.8% | 345,200 | +34.5% | 0.03% | -22.9% |
Q3 2021 | $27,054,000 | +150.0% | 256,700 | +216.5% | 0.04% | +169.2% |
Q1 2021 | $10,821,000 | +15.0% | 81,100 | -55.6% | 0.01% | +44.4% |
Q1 2020 | $9,412,000 | -27.4% | 182,831 | -41.3% | 0.01% | -10.0% |
Q4 2019 | $12,961,000 | +8.7% | 311,631 | -15.5% | 0.01% | 0.0% |
Q3 2019 | $11,925,000 | -12.0% | 368,631 | -5.1% | 0.01% | -16.7% |
Q2 2019 | $13,548,000 | +173.6% | 388,531 | +131.5% | 0.01% | +140.0% |
Q1 2019 | $4,952,000 | +869.1% | 167,800 | +662.7% | 0.01% | +400.0% |
Q4 2018 | $511,000 | – | 22,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |